A partir de January 4th, we have firmó unn anual CRO acuerdo with Sun Bio Inc. for non-clinical eficacia testing and toxicity testing services for drugs under desarrollo.
A través de esto acuerdo, we will maintain investigación colaboración from the preclinical phase through to ensayo clínicos for PEG drugs being developed by Sun Bio, and use this as an opportunity to deepen cooperación in drug and product desarrollo based on mutual trust and good faith.
This colaboración was establecido on the basis of trust in RudaCure's eficacia testing and toxicity systems. RudaCure actualmente está conducting eficacia verification, pharmacokinetic studies, and toxicity testing for drugs from Sun Bio, Seoul National University J-MAX, dental product developer ODS, Daewoong Pharmaceutical, and Vivozon.